Bicara Therapeutics BCAX Income Statement (2023-2026)

NASDAQ BCAX
$18.56 -0.24 (-1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Bicara Therapeutics Quarterly Income Statement

Periods 12 quarters
Latest Jun 2026

Bicara Therapeutics reported net income of -$55.44M for the quarter ended Jun 2026. This income statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.58M0.64M0.64M1.02M10.90M16.81M54.53M54.56M54.61M56.60M65.55M65.93M
Operating items
Research & DevelopmentR&D 6.90M10.50M12.00M15.80M15.90M19.90M34.30M24.80M33.00M33.00M47.50M45.77M
Selling, General & AdministrativeSG&A 2.59M3.12M3.34M3.91M4.76M6.75M7.46M7.22M7.70M8.13M12.74M14.18M
Other Operating ExpensesOther Opex 0.04M0.06M0.03M0.04M-0.04M-0.02M0.03M-0.00M-0.03M-0.01M
Operating ExpensesOpex 9.53M13.69M15.37M19.75M20.63M26.64M41.79M32.02M40.68M41.12M60.24M59.95M
Operating IncomeOp. Inc -9.53M-13.69M-15.37M-19.75M-20.63M-26.64M-41.79M-32.02M-40.68M-41.12M-60.24M-59.95M
EBIT -9.53M-13.69M-15.37M-19.75M-20.63M-26.64M-41.79M-32.02M-40.68M-41.12M-60.24M-59.95M
Non-operating items
Interest & Investment IncomeInt & Inv Inc 0.01M1.30M2.87M2.70M3.15M5.87M5.01M4.68M4.39M3.79M4.08M4.58M
Non Operating IncomeNon Op. Inc. -13.31M1.25M2.87M2.70M3.15M5.87M5.01M4.68M4.39M3.79M4.08M4.58M
Net income details
EBT -22.84M-12.44M-12.51M-17.05M-17.48M-20.77M-36.77M-27.34M-36.29M-37.33M-56.16M-55.38M
Tax ProvisionsTaxes 0.01M0.00M0.19M0.07M0.05M0.04M0.05M0.05M0.06M
Profit After TaxPAT -22.84M-12.44M-12.51M-17.05M-17.48M-20.96M-36.85M-27.39M-36.33M-37.39M-56.21M-55.44M
Income from Continuing OperationsIncome (Continuing) -22.84M-12.44M-12.51M-17.05M-17.48M-20.96M-36.85M-27.39M-36.33M-37.39M-56.21M-55.44M
Consolidated Net IncomeConsol Net Inc. -22.84M-12.44M-12.51M-17.05M-17.48M-20.96M-36.85M-27.39M-36.33M-37.39M-56.21M-55.44M
Income towards Parent CompanyParent Net Inc -22.84M-12.44M-12.51M-17.05M-17.48M-20.96M-36.85M-27.39M-36.33M-37.39M-56.21M-55.44M
Net Income towards Common StockholdersNet Income -22.84M-12.44M-12.51M-17.05M-17.48M-20.96M-36.85M-27.39M-36.33M-37.39M-56.21M-55.44M
Additional items
EPS (Basic) -38.23-21.44-18.94-19.01-1.60-1.25-0.68-0.50-0.67-0.68-0.93-0.82
EPS (Diluted) -38.23-21.44-18.94-19.01-1.60-1.25-0.68-0.50-0.67-0.68-0.93-0.82
Shares Outstanding 0.60M0.58M0.66M0.90M10.90M16.81M54.46M54.54M54.56M54.68M60.72M67.93M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.60M0.58M0.66M0.90M10.90M16.81M54.46M54.54M54.56M54.68M60.72M67.93M
EBITDA -13.67M-15.36M-19.74M-20.61M-26.62M-41.77M-32.00M-40.65M-41.08M-60.20M-59.91M

Bicara Therapeutics Income Statement API

Pull Bicara Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BCAX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY